With more than 5,000 installations worldwide, the Swiss company Hocoma is the world-leading med-tech brand for efficient solutions and services with advanced technologies for human movement therapy across the entire continuum of rehabilitation.
Hocoma develops robotic and sensor-based medical devices to rehabilitate gait and balance, arm and hand function or to increase strength, coordination and endurance. Their therapy solutions support the treatment of patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, cerebral palsy or other neurological diseases and injuries as well as low back pain patients.
Moreover, they assist with clinical application and clinical integration services while providing financial and marketing support as well as technical services to ensure a smooth transition from purchase to daily use in the clinic.
All Hocoma solutions are developed, manufactured and continuously improved in close cooperation with researchers, clinical partners and patient feedback.
With a hub in Singapore, a strong partnership with DIH International in Hong Kong and various local sales partners, Hocoma ensures a strong and successful presence in Asia-Pacific markets.
“With demographic changes happening, the demand for efficient therapies is growing. Our technologies enable healthcare providers to offer higher intensity therapy and thus improve therapy outcomes,” states Gery Colombo, founder and CEO of Hocoma. “We will improve millions of lives by providing functional and efficient solutions that set the standards for human movement therapy.”
